Compare DXR & QUCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | DXR | QUCY |
|---|---|---|
| Founded | 1970 | 2008 |
| Country | United States | Germany |
| Employees | N/A | 13 |
| Industry | Medical/Dental Instruments | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 59.0M | 48.8M |
| IPO Year | 1995 | 2021 |
| Metric | DXR | QUCY |
|---|---|---|
| Price | $9.26 | $1.72 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 2.2K | ★ 22.1M |
| Earning Date | 02-27-2026 | 06-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | ★ $1,446,345.00 | N/A |
| Revenue This Year | $44,935.22 | $74.34 |
| Revenue Next Year | $74.79 | $171.48 |
| P/E Ratio | $33.83 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $8.45 | $0.30 |
| 52 Week High | $14.76 | $4.93 |
| Indicator | DXR | QUCY |
|---|---|---|
| Relative Strength Index (RSI) | 38.42 | 44.10 |
| Support Level | $9.21 | $0.38 |
| Resistance Level | $11.40 | $4.93 |
| Average True Range (ATR) | 0.68 | 0.36 |
| MACD | -0.13 | -0.19 |
| Stochastic Oscillator | 0.00 | 0.85 |
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA offers unmatched, real-time, precise data via its rapid, hand-held, lab-based system.
Quantum Cyber NV is focused on building a diversified platform at the intersection of quantum computing and cybersecurity. It aims to secure critical infrastructure and data against these emerging threats.